Evidence map›Paper›PMID 36056073›Full record

ArticleScientific reports2022

Selective transfer of maternal antibodies in preterm and fullterm children.

Sepideh Dolatshahi, Audrey L Butler, Christian Pou, Ewa Henckel, Anna Karin Bernhardsson, Anna Gustafsson, Kajsa Bohlin, Sally A Shin, Douglas A Lauffenburger, Petter Brodin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Sepideh Dolatshahi *Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Audrey L Butler *Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Christian Pou *Science for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Ewa HenckelScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Anna Karin BernhardssonScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Anna GustafssonDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Kajsa BohlinDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Sally A ShinRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Douglas A LauffenburgerDepartment of Biological Engineering and Center for Gynepathology Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Petter BrodinScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. petter.brodin@ki.se.
Galit AlterRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. galter@mgh.harvard.edu.
Karolinska Institutet · SERagon Institute of MGH, MIT and Harvard · USKarolinska University Hospital · SEMassachusetts Institute of Technology · USScience for Life Laboratory · SEUniversity of Virginia · US

Funding

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Bryan Briney · 2018 to 2026
$32.0M
Demystifying the antiviral activity of the IgG3+ antibody responseR37AI080289 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALTER, GALIT · 2015 to 2022
$5.8M
Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseU01CA260476 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BAROUCH, DAN H. · 2020 to 2024
$3.7M
SARS-CoV-2 Variant TestingR01AI146785 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LINGWOOD, DANIEL · 2020 to 2024
$3.3M
CHLAMYDIA PNEUMONIAE AND MACROPHAGES IN ATHEROSCLEROSISR01AI042790 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI BYRNE, GERALD IRWIN · 1999 to 2003
$983k
Bill & Melinda Gates Foundation INV-001650NCI NIH HHS U01 CA260476NIAID NIH HHS R01 AI042790NIAID NIH HHS R01 AI146785NIAID NIH HHS R37 AI080289NIAID NIH HHS U19 AI135995NIH HHS 3R37AI080289-11S1NIH HHS 75N93019C00052
6 · The paper itself

Abstract

Preterm newborns are more likely to suffer from infectious diseases at birth compared to children delivered at term. Whether this is due to compromised cellular, humoral, or organ-specific development remains unclear. To begin to define whether maternal-fetal antibody transfer profiles differ across preterm (PT) and fullterm (FT) infants, the overall quantity and functional quality of an array of 24 vaccine-, endemic pathogen-, and common antigen-specific antibodies were assessed across a cohort of 11 PT and 12 term-delivered maternal:infant pairs from birth through week 12. While total IgG levels to influenza, pneumo, measles, rubella, EBV, and RSV were higher in FT newborns, selective Fc-receptor binding antibodies was noted in PT newborns. In fact, near equivalent antibody-effector functions were observed across PT and FT infants, despite significant quantitative differences in transferred antibody levels. Moreover, temporal transfer analysis revealed the selective early transfer of FcRn, FcγR2, and FcγR3 binding antibodies, pointing to differential placental sieving mechanisms across gestation. These data point to selectivity in placental transfer at distinct gestational ages, to ensure that children are endowed with the most robust humoral immunity even if born preterm.

Indexed as

Infant, PrematureRubellaAntibodies, ViralChildFemaleGestational AgeHumansImmunoglobulin GInfantInfant, NewbornPlacentaPregnancyAntibodies, ViralImmunoglobulin G

Identifiers

PMID36056073
PMCPMC9440225
OpenAlexW4294243531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.